Milmed Unico AB has recently received a positive statement from the International Patent Office in the examination of patent application no. PCT/SE2022/050656, YEAST FOR THE TREATMENT OF INFLAMMATION.

The international authority makes an assessment as to whether the invention is patentable based on the submitted claims.

The reviewer means that claim 3 ( … wherein the inflammation is inflammatory bowel disease (IBD), such as Crohn’s disease or ulcerative colitis; or irritable bowel syndrome (IBS) meets the requirements for novelty and inventive step.